Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220369 · ClinicalTrials.gov registry record · NA
Gut Mini-Pill Study
A NA study of Gut -Microbiota, sponsored by Tufts University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07220369: Recruiting NA study of Gut -Microbiota, sponsored by Tufts University.
NCT07220369 is a NA study of Gut -Microbiota that is actively recruiting participants, run by Tufts University. The registered enrollment target is 30 participants, below the 46-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220369, a NA study of Gut -Microbiota, is actively recruiting participants, sponsored by Tufts University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this proof-of-concept study in humans is to determine if a noninvasive, ingestible device, called a "mini-pill", can collect gastrointestinal (GI) luminal content samples from 2 different locations along the GI tract after consumption of diets differing in protein source (meat and plant-based meat alternatives). The mini-pills will be recovered in the stool. We will analyze the microbial profile of the mini-pill contents and in stool, and also measure blood biomarkers related to cardiometabolic risk, to better understand the relationship between diet, microbiota and health.
Primary Outcome
Using luminal content collected by the gut mini-pill to compare the microbiome and metabolome after subjects consumed a meat-rich and plant-based meat alternative-rich diet
Conditions Studied
Interventions
- OTHER plant-based meat alternative entrees
- DEVICE mini-pill
- OTHER meat based entree
Study Locations (1)
Massachusetts
- Jean Mayer Human Nutrition Research Center on Aging - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-09-08 |
| Est. Completion | 2028-08 |
| Phase | NA |
What NCT07220369 shows while recruiting
NCT07220369 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 46-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Gut -Microbiota appearing as the primary indexed condition, and to 3 interventions - of which plant-based meat alternative entrees is the first listed.
NCT07220369 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07220369 about?
NCT07220369 is a clinical study titled "Gut Mini-Pill Study". The purpose of this proof-of-concept study in humans is to determine if a noninvasive, ingestible device, called a "mini-pill", can collect gastrointestinal (GI) luminal content samples from 2 different locations along the GI tract after consumption of diets differing in protein source (meat and pla...
What is the current status of trial NCT07220369?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-09-08. Estimated completion is 2028-08.
What conditions does trial NCT07220369 study?
This clinical trial studies the following conditions: Gut -Microbiota.
What interventions are being tested in trial NCT07220369?
The interventions under investigation include: plant-based meat alternative entrees (OTHER), mini-pill (DEVICE), meat based entree (OTHER).
Who is sponsoring clinical trial NCT07220369?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220369 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut -Microbiota
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07220369's enrollment target sits among peer trials
30 7th of 9 higher than 2 of 9 other Gut -Microbiota trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gut -Microbiota trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Walnuts as an Infant Solid Food for Health
RECRUITING · NA
-
Dietary Wild Blueberries and Joint Health
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
Peanuts for Cardiometabolic, Brain, and Intestinal Health
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
RECRUITING · NA
-
Effects of Grape Powder on Psychological Distress and Gut Microbiota in College Students
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI